======= NR4A1 ======= == Gene Information == * **Official Symbol**: NR4A1 * **Official Name**: nuclear receptor subfamily 4 group A member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3164|3164]] * **UniProt**: [[https://www.uniprot.org/uniprot/P22736|P22736]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NR4A1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NR4A1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/139139|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Orphan nuclear receptor. May act concomitantly with NURR1 in regulating the expression of delayed-early genes during liver regeneration. Binds the NGFI-B response element (NBRE) 5'- AAAAGGTCA-3' (By similarity). May inhibit NF-kappa-B transactivation of IL2. Participates in energy homeostasis by sequestrating the kinase STK11 in the nucleus, thereby attenuating cytoplasmic AMPK activation. {ECO:0000250, ECO:0000269|PubMed:15466594, ECO:0000269|PubMed:22983157}. |zf-C4| |Hormone recep| |response to corticotropin-releasing hormone| |cellular response to corticotropin-releasing hormone stimulus| |endothelial cell chemotaxis| |regulation of type B pancreatic cell proliferation| |glucocorticoid receptor binding| |cell migration involved in sprouting angiogenesis| |blood vessel endothelial cell migration| |cellular response to vascular endothelial growth factor stimulus| |nuclear receptor activity| |steroid hormone receptor activity| |sprouting angiogenesis| |endothelial cell migration| |epithelial cell migration| |epithelium migration| |tissue migration| |positive regulation of endothelial cell proliferation| |fat cell differentiation| |cellular response to fibroblast growth factor stimulus| |response to fibroblast growth factor| |steroid hormone mediated signaling pathway| |regulation of endothelial cell proliferation| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |ameboidal-type cell migration| |transcription initiation from RNA polymerase II promoter| |cellular response to steroid hormone stimulus| |positive regulation of epithelial cell proliferation| |transcription factor complex| |cell chemotaxis| |DNA-templated transcription, initiation| |nuclear membrane| |cellular response to peptide hormone stimulus| |RNA polymerase II regulatory region sequence-specific DNA binding| |angiogenesis| |cellular response to peptide| |response to steroid hormone| |regulation of epithelial cell proliferation| |response to peptide hormone| |blood vessel morphogenesis| |sequence-specific DNA binding| |DNA-binding transcription activator activity, RNA polymerase II-specific| |response to peptide| |transcription by RNA polymerase II| |blood vessel development| |protein heterodimerization activity| |cellular response to growth factor stimulus| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |cellular response to lipid| |response to growth factor| |cellular response to organic cyclic compound| |chemotaxis| |taxis| |negative regulation of cell cycle| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |tube morphogenesis| |cellular response to nitrogen compound| |zinc ion binding| |tube development| |response to lipid| |circulatory system development| |anatomical structure formation involved in morphogenesis| |response to hormone| |positive regulation of cell population proliferation| |response to organic cyclic compound| |cell migration| |response to organonitrogen compound| |cellular response to oxygen-containing compound| |cell motility| |localization of cell| |response to nitrogen compound| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |organic cyclic compound biosynthetic process| |locomotion| |DNA binding| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |movement of cell or subcellular component| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-2.01| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.99| |[[:results:exp73|LJH685 5μM R02 exp73]]|-1.73| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|1.75| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|1.82| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6370 * **Expression level (log2 read counts)**: 3.52 {{:chemogenomics:nalm6 dist.png?nolink |}}